Loading profile…
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
DBA: N/A
EIN 20-3177033 · Snapshot of IRS recognition, filing currency, financial health, and governance.
To create and distribute research tools which stimulate the development of drugs to improve the cognitive deficits in schizophrenia.
Principal Officer
Keith Nuechterlein
Total Revenue
$120K
FY2024
Total Expenses
$304K
FY2024
Net Assets
$994K
Program Ratio
78.6%
expenses on programs
Employees
1
Volunteers
0
Board Members
4
Voting
4
Independent
8 answers compiled from IRS Form 990, BMF, Pub 78, and the Auto-Revocation List.